V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627235 | 330006899 | EE813 | 37 | null | 1 | 2013-06-04 | CISPLATIN | 330005701 | 330003674 | 330006901 |
| 16627236 | 330006899 | ED301 | 55 | X721 | 1 | 2013-06-05 | DOXORUBICIN | 330005701 | 330003674 | 330006901 |
| 16627237 | 330006899 | ERA20 | 65 | X721 | 1 | 2013-06-06 | CISPLATIN | 330005701 | 330003674 | 330006901 |
| 16627238 | 330006900 | E0N03 | 150 | null | 1 | 2016-12-23 | IFOSFAMIDE | 330005701 | 330003675 | 330006902 |
| 16627239 | 330006900 | EEI00 | 3200 | null | 1 | 2016-12-23 | IFOSFAMIDE | 330005701 | 330003675 | 330006902 |
| 16627240 | 330006900 | EEI00 | 4800 | null | null | 2016-12-24 | TRIAL | 330005701 | 330003675 | 330006902 |
| 16627241 | 330006904 | EK1EN | 55 | X724 | 1 | 2016-09-26 | ETOPOSIDE | 330005719 | 330003680 | 330006906 |
| 16627242 | 330006904 | EEI00 | 100 | null | null | 2016-09-26 | IFOSFAMIDE | 330005719 | 330003680 | 330006906 |
| 16627243 | 330006904 | ETG | 21 | x724 | 1 | 2016-09-26 | CYTARABINE | 330005719 | 330003680 | 330006906 |
| 16627244 | 330006904 | EK1EN | 4410 | null | 1 | 2016-10-03 | NOT CHEMO | 330005719 | 330003680 | 330006906 |
| 16627245 | 330006904 | EE813 | 110 | null | 1 | 2016-10-03 | VINCRISTINE | 330005719 | 330003680 | 330006906 |
| 16627246 | 330006904 | EJR | 3000 | X724 | 1 | 2016-10-03 | IFOSFAMIDE | 330005719 | 330003680 | 330006906 |
| 16627247 | 330006904 | EOI | 500 | X721 | 1 | 2016-10-04 | CARBOPLATIN | 330005719 | 330003680 | 330006906 |
| 16627248 | 330006905 | EGQ01 | 400 | N/A | 1 | 2014-07-18 | TOPOTECAN | 330005721 | 330003681 | 330006907 |
| 16627249 | 330006906 | EQM | 170 | X729 | 1 | 2017-06-14 | IFOSFAMIDE | 330005721 | 330003682 | 330006908 |
| 16627250 | 330006907 | EGQ01 | 1950 | X728 | 0 | 2017-01-25 | TRIAL | 330005735 | 330003686 | 330006909 |
| 16627251 | 330006908 | EOI | 1400 | null | 1 | 2016-05-24 | NIVOLUMAB | 330005735 | 330003688 | 330006910 |
| 16627252 | 330006909 | EEI00 | 1.05 | X724 | 1 | 2014-08-11 | NOT CHEMO | 330005748 | 330010332 | 330006911 |
| 16627253 | 330006910 | ETG | 1650 | X729 | 1 | 2015-03-22 | IFOSFAMIDE | 330005768 | 330003690 | 330006912 |
| 16627254 | 330006910 | ETG | 1880 | null | 1 | 2015-03-22 | DACTINOMYCIN | 330005768 | 330003690 | 330006912 |
| 16627255 | 330006910 | EEI00 | 50 | X724 | 1 | 2015-03-22 | IFOSFAMIDE | 330005768 | 330003690 | 330006912 |
| 16627256 | 330006910 | EOI | 55 | null | 1 | 2015-03-22 | TRIAL | 330005768 | 330003690 | 330006912 |
| 16627257 | 330006911 | EEI00 | 2 | null | 6 | 2016-09-27 | ETOPOSIDE | 330005768 | 330003690 | 330006913 |
| 16627258 | 330006911 | EGQ01 | 6100 | null | 1 | 2016-09-27 | NOT CHEMO | 330005768 | 330003690 | 330006913 |
| 16627259 | 330006911 | EOF | 20 | null | null | 2016-10-11 | TOPOTECAN | 330005768 | 330003690 | 330006913 |
| 16627260 | 330006911 | EEI00 | 4800 | X724 | 2 | 2016-10-18 | NOT CHEMO | 330005768 | 330003690 | 330006913 |
| 16627261 | 330006912 | EEI00 | 3200 | N/A | 1 | 2016-10-05 | NOT CHEMO | 330005788 | 330003691 | 330006914 |
| 16627262 | 330006912 | EK1EN | 0.75 | X724 | 1 | 2016-10-30 | DOCETAXEL | 330005788 | 330003691 | 330006914 |
| 16627263 | 330006912 | EEI00 | 10 | X721 | 1 | 2016-10-30 | TOPOTECAN | 330005788 | 330003691 | 330006914 |
| 16627264 | 330006912 | EEI00 | 3040 | X724 | 1 | 2016-10-30 | TOPOTECAN | 330005788 | 330003691 | 330006914 |
| 16627265 | 330006912 | EEI00 | 55 | X724 | 2 | 2016-11-18 | NOT CHEMO | 330005788 | 330003691 | 330006914 |
| 16627266 | 330006914 | EJR | 1680 | null | 1 | 2013-11-06 | MESNA | 330005788 | 330003691 | 330006916 |
| 16627267 | 330006914 | EEI00 | 3100 | null | 1 | 2013-11-12 | IFOSFAMIDE | 330005788 | 330003691 | 330006916 |
| 16627268 | 330006914 | EEI00 | 500 | X724 | 1 | 2013-11-12 | DOCETAXEL | 330005788 | 330003691 | 330006916 |
| 16627269 | 330006914 | EGU08 | 3840 | X722 | 2 | 2013-11-12 | IFOSFAMIDE | 330005788 | 330003691 | 330006916 |
| 16627270 | 330006915 | EEI00 | 1680 | N/A | 1 | 2017-08-04 | ETOPOSIDE | 330005832 | 330003693 | 330006917 |
| 16627271 | 330006915 | EGU08 | 0.9 | X724 | 1 | 2017-08-19 | DACTINOMYCIN | 330005832 | 330003693 | 330006917 |
| 16627272 | 330006915 | EGU08 | 2 | X724 | 1 | 2017-08-26 | OXALIPLATIN | 330005832 | 330003693 | 330006917 |
| 16627273 | 330006915 | EK1EN | 1.9 | X724 | 1 | 2017-08-29 | ETOPOSIDE | 330005832 | 330003693 | 330006917 |
| 16627274 | 330006915 | EUZ | 1 | X721 | 1 | 2017-08-29 | MULTIPLE | 330005832 | 330003693 | 330006917 |
| 16627275 | 330006916 | EN723 | 1000 | X724 | 1 | 2018-01-26 | IFOSFAMIDE | 330005833 | 330007989 | 330006918 |
| 16627276 | 330006916 | EK1EN | 10 | X724 | 1 | 2018-02-02 | MULTIPLE | 330005833 | 330007989 | 330006918 |
| 16627277 | 330006917 | EZ102 | 300 | null | 1 | 2017-04-08 | DAUNORUBICIN | 330005834 | 330010335 | 330006919 |
| 16627278 | 330006917 | EE813 | 170 | X729 | 1 | 2017-04-09 | METHOTREXATE | 330005834 | 330010335 | 330006919 |
| 16627279 | 330006917 | EKD50 | 1800 | X729 | 1 | 2017-04-09 | METHOTREXATE | 330005834 | 330010335 | 330006919 |
| 16627280 | 330006917 | EEI00 | 0.95 | null | 2 | 2017-04-09 | IFOSFAMIDE | 330005834 | 330010335 | 330006919 |
| 16627281 | 330006918 | ECL01 | 6 | null | 2 | null | DAUNORUBICIN | 330005834 | 330010335 | 330006920 |
| 16627282 | 330006918 | EC4 | 150 | null | 1 | null | STEROID | 330005834 | 330010335 | 330006920 |
| 16627283 | 330006918 | EUJ01 | 606 | X724 | 1 | null | NOT CHEMO | 330005834 | 330010335 | 330006920 |
| 16627284 | 330006918 | EEI00 | 170 | null | 1 | null | DACTINOMYCIN | 330005834 | 330010335 | 330006920 |